Cargando…

Remission in Cushing disease with cabergoline

Detalles Bibliográficos
Autores principales:	Gopal, Raju, Bandgar, Tushar, Menon, Padma, Shah, Nalini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2008
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074420/ https://www.ncbi.nlm.nih.gov/pubmed/18500188 http://dx.doi.org/10.5144/0256-4947.2008.224

Ejemplares similares

Remission with Cabergoline in Adolescent Boys with Cushing’s Disease
por: Güven, Ayla, et al.
Publicado: (2013)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017)

Cushing's syndrome: Stepwise approach to diagnosis
por: Lila, Anurag R., et al.
Publicado: (2011)

Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
por: Bansal, Prachi, et al.
Publicado: (2017)

Renal manifestations of primary hyperparathyroidism
por: Lila, Anurag Ranjan, et al.
Publicado: (2012)

Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?
por: Budyal, Sweta, et al.
Publicado: (2015)

MON-312 The Effects of Cabergoline in Pre-Surgical and Recurrence Periods of Cushing’s Disease Patients
por: Pereira, Ana Julia Garcia, et al.
Publicado: (2020)

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease
por: Feelders, Richard A., et al.
Publicado: (2023)

First Trimester Thyroid Function Tests: Normative Data from Western India
por: Nambiar, Vimal M., et al.
Publicado: (2018)

Cytochrome P450 Oxidoreductase Deficiency: Novel Cause of Ambiguity with Primary Amenorrhea
por: Khadilkar, Kranti Shreesh, et al.
Publicado: (2017)

Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment
por: Miceli, Diego D, et al.
Publicado: (2021)

Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment
por: Miceli, Diego D, et al.
Publicado: (2021)

Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2014)

Promise and pitfalls of molecular markers of thyroid nodules
por: Jadhav, S., et al.
Publicado: (2012)

Cabergoline Effectively Induced Remission of Prolactinoma in a 9-year-old Japanese Boy
por: Sano, Hitomi, et al.
Publicado: (2009)

Hypophosphatemic rickets
por: Jagtap, Varsha S., et al.
Publicado: (2012)

Cushing Mortality in Remission: Not Out of the Woods
por: Kelsall, Alan, et al.
Publicado: (2022)

Management issues with exogenous steroid therapy
por: Patt, Hiren, et al.
Publicado: (2013)

A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas
por: Mishra, Rakesh, et al.
Publicado: (2021)

Prevalence of upper airway obstruction in patients with apparently asymptomatic euthyroid multi nodular goitre
por: Menon, Sunil K., et al.
Publicado: (2011)

The Effect of Cabergoline on Clinical and Laboratory Findings in Active Rheumatoid Arthritis
por: Mobini, M, et al.
Publicado: (2011)

Alveolar Soft Part Sarcoma Presenting as Hypervascular Adrenal Metastasis
por: Goroshi, Manjunath, et al.
Publicado: (2018)

Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
por: Diwaker, Chakra, et al.
Publicado: (2022)

Metabolic status in children with Cushing’s disease and its relationship with remission
por: Moszczyńska, Elżbieta, et al.
Publicado: (2023)

Hyperphagic short stature: A case report and review of literature
por: Jagtap, Varsha S., et al.
Publicado: (2012)

Aortoarteritis: Could it be a form of catecholamine-induced vasculitis?
por: Sarathi, Vijaya, et al.
Publicado: (2013)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

Is cushing's syndrome remission associated with diabetes regression? Analysis of a retrospective cohort of 108 patients with cushing's disease
por: Londero, Thizá Massaia, et al.
Publicado: (2015)

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021)

Current concepts in blood glucose monitoring
por: Khadilkar, Kranti Shreesh, et al.
Publicado: (2013)

Prevalence and Impact of Thyroid Disorders on Maternal Outcome in Asian-Indian Pregnant Women
por: Nambiar, Vimal, et al.
Publicado: (2011)

Vanishing tumor in pregnancy
por: Vimal, M. V., et al.
Publicado: (2012)

Demystifying “Steroid Withdrawal” During Remission in Cushing's Disease: Is Mineralocorticoid Replacement the Answer?
por: Jain, Nimisha, et al.
Publicado: (2019)

The Role of Serum Inflammation-Based Scores in Diagnosis and Assessing Remission in Cushing’s Disease
por: Canat, Muhammed Masum, et al.
Publicado: (2023)

Mental Fatigue and Executive Dysfunction in Patients with Cushing's Syndrome in Remission
por: Papakokkinou, Eleni, et al.
Publicado: (2015)

Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
por: Vogel, Frederick, et al.
Publicado: (2020)

Abstract 70: High dose intravenous therapy augments complete anterior pituitary hormoanl recovery in primary autoimmune hypophysitis
por: Brijesh, K, et al.
Publicado: (2022)

A Study on Psychiatric Disorders, Body Image Disturbances, and Self-Esteem in Patients of Cushing’s Disease
por: Sharma, Akanksha, et al.
Publicado: (2018)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cfkgru7lkbh42g41fqp0d197l0